{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:17:40Z","timestamp":1790918260597,"version":"4.1.0"},"publisher-location":"Berlin, Heidelberg","reference-count":175,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642006623","type":"print"},{"value":"9783642006630","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010]]},"DOI":"10.1007\/978-3-642-00663-0_1","type":"book-chapter","created":{"date-parts":[[2009,11,3]],"date-time":"2009-11-03T16:31:14Z","timestamp":1257265874000},"page":"3-27","source":"Crossref","is-referenced-by-count":44,"title":["Drug-Induced Liver Injury"],"prefix":"10.1007","author":[{"given":"Michael","family":"Holt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,9,21]]},"reference":[{"key":"1_CR1_1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S1590-8658(02)80043-3","volume":"34","author":"C Abbiati","year":"2002","unstructured":"Abbiati C, Vecchi M, Rossi G, Donata MF, de Franchis R (2002) Inappropriate pemoline therapy leading to acute liver failure and liver transplantation. Dig Liver Dis 34:447\u2013451","journal-title":"Dig Liver Dis"},{"key":"1_CR2_1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1136\/pgmj.63.735.55","volume":"63","author":"Z Ackerman","year":"1987","unstructured":"Ackerman Z, Levy M (1987) Hypersensitivity reactions to drugs in acquired immunodeficiency syndrome. Postgrad Med J 63:55\u201356","journal-title":"Postgrad Med J"},{"key":"1_CR3_1","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/hep.20205","volume":"39","author":"GP Aithal","year":"2004","unstructured":"Aithal GP, Ramsay L, Daly AK, Sonchit N, Leathart JB, Alexander G, Kenna JG, Caldwell J, Day CP (2004) Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity. Hepatology 39:1430\u20131440","journal-title":"Hepatology"},{"key":"1_CR4_1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.7326\/0003-4819-132-2-200001180-00006","volume":"132","author":"J Al Salman","year":"2000","unstructured":"Al Salman J, Arjomand H, Kemp DG, Mittal M (2000) Hepatocellular injury in a patient receiving rosiglitazone. A case report. Ann Int Med 132:121\u2013124","journal-title":"Ann Int Med"},{"key":"1_CR5_1","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","volume":"129","author":"RJ Andrade","year":"2005","unstructured":"Andrade RJ, Lucena MI, Fernandez MC, Pelaez G, Pachkoria K, Garcia-Ruiz E, Garcia-Munoz B, Gonzalez-Grande R, Pizarro A, Duran JA, Jimenez M, Rodrigo L, Romero-Gomez M, Navarro JM, Planas R, Costa J, Borras A, Soler A, Salmeron J, Martin-Vivaldi R (2005) Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 129:512\u2013521","journal-title":"Gastroenterology"},{"key":"1_CR6_1","doi-asserted-by":"publisher","first-page":"15028","DOI":"10.1074\/jbc.M200497200","volume":"277","author":"A Asea","year":"2002","unstructured":"Asea A, Rehli M, Kabingu E, Boch JA, Bare O, Auron PE, Stevenson MA, Calderwood SK (2002) Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 277:15028\u201315034","journal-title":"J Biol Chem"},{"key":"1_CR7_1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1001\/jama.1963.73700140004017","volume":"184","author":"FJ AYD Jr","year":"1963","unstructured":"AYD FJ Jr (1963) Chlorpromazine: ten years' experience. JAMA 184:51\u201354","journal-title":"JAMA"},{"key":"1_CR8_1","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/0009-9236(95)90078-0","volume":"58","author":"OM Bakke","year":"1995","unstructured":"Bakke OM, Manocchia M, de Abajo F, Kaitin KI, Lasagna L (1995) Drug safety discontinuations in the United Kingdom, the United States, and Spain from 1974 through 1993: a regulatory perspective. Clin Pharmacol Ther 58:108\u2013117","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl 2","key":"1_CR9_1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0168-8278(97)80494-1","volume":"26","author":"F Ballet","year":"1997","unstructured":"Ballet F (1997) Hepatotoxicity in drug development: detection, significance and solutions. J Hepatol 26(Suppl 2):26\u201336","journal-title":"J Hepatol"},{"key":"1_CR10_1","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/hep.1840220320","volume":"22","author":"AT Banks","year":"1995","unstructured":"Banks AT, Zimmerman HJ, Ishak KG, Harter JG (1995) Diclofenac-associated hepatotoxicity: analysis of 180 cases reported to the Food and Drug Administration as adverse reactions. Hepatology 22:820\u2013827","journal-title":"Hepatology"},{"key":"1_CR11_1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1055\/s-2003-42640","volume":"23","author":"W Bernal","year":"2003","unstructured":"Bernal W (2003) Changing patterns of causation and the use of transplantation in the United Kingdom. Semin Liver Dis 23:227\u2013237","journal-title":"Semin Liver Dis"},{"key":"1_CR12_1","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/S0016-5085(98)70590-6","volume":"114","author":"A Berson","year":"1998","unstructured":"Berson A, De BV, Letteron P, Robin MA, Moreau C, El Kahwaji J, Verthier N, Feldmann G, Fromenty B, Pessayre D (1998) Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. Gastroenterology 114:764\u2013774","journal-title":"Gastroenterology"},{"key":"1_CR13_1","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1126\/science.1075565","volume":"298","author":"A Biragyn","year":"2002","unstructured":"Biragyn A, Ruffini PA, Leifer CA, Klyushnenkova E, Shakhov A, Chertov O, Shirakawa AK, Farber JM, Segal DM, Oppenheim JJ, Kwak LW (2002) Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 298:1025\u20131029","journal-title":"Science"},{"key":"1_CR14_1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/hep.20800","volume":"42","author":"E Bjornsson","year":"2005","unstructured":"Bjornsson E, Olsson R (2005) Outcome and prognostic markers in severe drug-induced liver disease. Hepatology 42:481\u2013489","journal-title":"Hepatology"},{"key":"1_CR15_1","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.jhep.2005.12.016","volume":"44","author":"E Bjornsson","year":"2006","unstructured":"Bjornsson E, Nordlinder H, Olsson R (2006) Clinical characteristics and prognostic markers in disulfiram-induced liver injury. J Hepatol 44:791\u2013797","journal-title":"J Hepatol"},{"key":"1_CR16_1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0016-5085(19)32568-5","volume":"69","author":"M Black","year":"1975","unstructured":"Black M, Mitchell JR, Zimmerman HJ, Ishak KG, Epler GR (1975) Isoniazid-associated hepatitis in 114 patients. Gastroenterology 69:289\u2013302","journal-title":"Gastroenterology"},{"key":"1_CR17_1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1006\/taap.1995.1125","volume":"133","author":"ME Blazka","year":"1995","unstructured":"Blazka ME, Wilmer JL, Holladay SD, Wilson RE, Luster MI (1995) Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 133:43\u201352","journal-title":"Toxicol Appl Pharmacol"},{"key":"1_CR18_1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/019262339602400206","volume":"24","author":"ME Blazka","year":"1996","unstructured":"Blazka ME, Elwell MR, Holladay SD, Wilson RE, Luster MI (1996) Histopathology of acetaminophen-induced liver changes: role of interleukin 1 alpha and tumor necrosis factor alpha. Toxicol Pathol 24:181\u2013189","journal-title":"Toxicol Pathol"},{"key":"1_CR19_1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3109\/10408449509089888","volume":"25","author":"UA Boelsterli","year":"1995","unstructured":"Boelsterli UA, Zimmerman HJ, Kretz-Rommel A (1995) Idiosyncratic liver toxicity of nonsteroidal antiinflammatory drugs: molecular mechanisms and pathology. Crit Rev Toxicol 25:207\u2013235","journal-title":"Crit Rev Toxicol"},{"key":"1_CR20_1","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1021\/tx980136z","volume":"12","author":"E Bonierbale","year":"1999","unstructured":"Bonierbale E, Valadon P, Pons C, Desfosses B, Dansette PM, Mansuy D (1999) Opposite behaviors of reactive metabolites of tienilic acid and its isomer toward liver proteins: use of specific anti-tienilic acid-protein adduct antibodies and the possible relationship with different hepatotoxic effects of the two compo. Chem Res Toxicol 12:286\u2013296","journal-title":"Chem Res Toxicol"},{"key":"1_CR21_1","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0026-895X(25)10602-0","volume":"45","author":"M Bourdi","year":"1994","unstructured":"Bourdi M, Tinel M, Beaune PH, Pessayre D (1994) Interactions of dihydralazine with cytochromes P4501A: a possible explanation for the appearance of anti-cytochrome P4501A2 autoantibodies. Mol Pharmacol 45:1287\u20131295","journal-title":"Mol Pharmacol"},{"key":"1_CR22_1","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1021\/tx000244x","volume":"14","author":"M Bourdi","year":"2001","unstructured":"Bourdi M, Amouzadeh HR, Rushmore TH, Martin JL, Pohl LR (2001) Halothane-induced liver injury in outbred guinea pigs: role of trifluoroacetylated protein adducts in animal susceptibility. Chem Res Toxicol 14:362\u2013370","journal-title":"Chem Res Toxicol"},{"key":"1_CR23_1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1053\/jhep.2002.30956","volume":"35","author":"M Bourdi","year":"2002","unstructured":"Bourdi M, Masubuchi Y, Reilly TP, Amouzadeh HR, Martin JL, George JW, Shah AG, Pohl LR (2002) Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase. Hepatology 35:289\u2013298","journal-title":"Hepatology"},{"key":"1_CR24_1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/WNL.46.2.465","volume":"46","author":"AE Bryant III","year":"1996","unstructured":"Bryant AE III, Dreifuss FE (1996) Valproic acid hepatic fatalities. III. U.S. experience since 1986. Neurology 46:465\u2013469","journal-title":"Neurology"},{"key":"1_CR25_1","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/sj.bjp.0703845","volume":"132","author":"C Burkhart","year":"2001","unstructured":"Burkhart C, von Greyerz S, Depta JP, Naisbitt DJ, Britschgi M, Park KB, Pichler WJ (2001) Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole-metabolite-specific human CD4+ T-cells. Br J Pharmacol 132:623\u2013630","journal-title":"Br J Pharmacol"},{"key":"1_CR26_1","first-page":"135","volume":"51","author":"FM Carney","year":"1972","unstructured":"Carney FM, Van Dyke RA (1972) Halothane hepatitis: a critical review. Anesth Analg 51:135\u2013160","journal-title":"Anesth Analg"},{"key":"1_CR27_1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4088\/JCP.v63n0208","volume":"63","author":"A Carvajal Garcia-Pando","year":"2002","unstructured":"Carvajal Garcia-Pando A, Garcia DP, Sanchez AS, Velasco MA, Rueda de Castro AM, Lucena MI (2002) Hepatotoxicity associated with the new antidepressants. J Clin Psychiatry 63:135\u2013137","journal-title":"J Clin Psychiatry"},{"key":"1_CR28_1","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1053\/j.gastro.2004.02.015","volume":"126","author":"N Chalasani","year":"2004","unstructured":"Chalasani N, Aljadhey H, Kesterson J, Murray MD, Hall SD (2004) Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity. Gastroenterology 126:1287\u20131292","journal-title":"Gastroenterology"},{"key":"1_CR29_1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/hep.22585","volume":"49","author":"L Cheng","year":"2009","unstructured":"Cheng L, You Q, Yin H, Holt M, Franklin C, Ju C (2009) Effect of polyI:C cotreatment on halothane-induced liver injury in mice. Hepatology 49:215\u2013226","journal-title":"Hepatology"},{"key":"1_CR30_1","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/j.1432-1033.1994.tb19082.x","volume":"223","author":"U Christen","year":"1994","unstructured":"Christen U, Quinn J, Yeaman SJ, Kenna JG, Clarke JB, Gandolfi AJ, Gut J (1994) Identification of the dihydrolipoamide acetyltransferase subunit of the human pyruvate dehydrogenase complex as an autoantigen in halothane hepatitis. Molecular mimicry of trifluoroacetyl-lysine by lipoic acid. Eur J Biochem 223:1035\u20131047","journal-title":"Eur J Biochem"},{"key":"1_CR31_1","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/428486a","volume":"428","author":"WH Chung","year":"2004","unstructured":"Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT (2004) Medical genetics: a marker for Stevens\u2013Johnson syndrome. Nature 428:486","journal-title":"Nature"},{"key":"1_CR32_1","first-page":"1182","volume":"8","author":"S Claudel","year":"1979","unstructured":"Claudel S, Euvrard P, Bory R, Chavaillon A, Paliard P (1979) Intra-hepatic cholestasis after taking a triacetyloleandomycin-estroprogestational combination. Nouv Presse Med 8:1182","journal-title":"Nouv Presse Med"},{"key":"1_CR33_1","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1056\/NEJM199306103282304","volume":"328","author":"SA Coopman","year":"1993","unstructured":"Coopman SA, Johnson RA, Platt R, Stern RS (1993) Cutaneous disease and drug reactions in HIV infection. N Engl J Med 328:1670\u20131674","journal-title":"N Engl J Med"},{"key":"1_CR34_1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.taap.2006.04.010","volume":"216","author":"C Cover","year":"2006","unstructured":"Cover C, Liu J, Farhood A, Malle E, Waalkes MP, Bajt ML, Jaeschke H (2006) Pathophysiological role of the acute inflammatory response during acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 216:98\u2013107","journal-title":"Toxicol Appl Pharmacol"},{"key":"1_CR35_1","first-page":"874","volume":"51","author":"M Dahms","year":"1996","unstructured":"Dahms M, Spahn-Langguth H (1996) Covalent binding of acidic drugs via reactive intermediates: detection of benoxaprofen and flunoxaprofen protein adducts in biological material. Pharmazie 51:874\u2013881","journal-title":"Pharmazie"},{"key":"1_CR36_1","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/hep.1840030421","volume":"3","author":"H Groot de","year":"1983","unstructured":"de Groot H, Noll T (1983) Halothane hepatotoxicity: relation between metabolic activation, hypoxia, covalent binding, lipid peroxidation and liver cell damage. Hepatology 3:601\u2013606","journal-title":"Hepatology"},{"key":"1_CR37_1","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1111\/j.1365-2036.2006.03117.x","volume":"24","author":"MB Valle De","year":"2006","unstructured":"De Valle MB, Av KV, Alem N, Olsson R, Bjornsson E (2006) Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic. Aliment Pharmacol Ther 24:1187\u20131195","journal-title":"Aliment Pharmacol Ther"},{"key":"1_CR38_1","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1097\/00002030-200012220-00011","volume":"14","author":"M Brinker den","year":"2000","unstructured":"den Brinker M, Wit FW, Wertheim-van Dillen PM, Jurriaans S, Weel J, van Leeuwen R, Pakker NG, Reiss P, Danner SA, Weverling GJ, Lange JM (2000) Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection. AIDS 14:2895\u20132902","journal-title":"AIDS"},{"key":"1_CR39_1","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1124\/jpet.106.110247","volume":"319","author":"X Deng","year":"2006","unstructured":"Deng X, Stachlewitz RF, Liguori MJ, Blomme EA, Waring JF, Luyendyk JP, Maddox JF, Ganey PE, Roth RA (2006) Modest inflammation enhances diclofenac hepatotoxicity in rats: role of neutrophils and bacterial translocation. J Pharmacol Exp Ther 319:1191\u20131199","journal-title":"J Pharmacol Exp Ther"},{"key":"1_CR40_1","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1124\/jpet.107.122069","volume":"322","author":"X Deng","year":"2007","unstructured":"Deng X, Luyendyk JP, Zou W, Lu J, Malle E, Ganey PE, Roth RA (2007) Neutrophil interaction with the hemostatic system contributes to liver injury in rats cotreated with lipopolysaccharide and ranitidine. J Pharmacol Exp Ther 322:852\u2013861","journal-title":"J Pharmacol Exp Ther"},{"key":"1_CR41_1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/toxsci\/kfn056","volume":"103","author":"JA Dykens","year":"2008","unstructured":"Dykens JA, Jamieson JD, Marroquin LD, Nadanaciva S, Xu JJ, Dunn MC, Smith AR, Will Y (2008) In vitro assessment of mitochondrial dysfunction and cytotoxicity of nefazodone, trazodone, and buspirone. Toxicol Sci 103:335\u2013345","journal-title":"Toxicol Sci"},{"issue":"Suppl 4","key":"1_CR42_1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/ajhp\/61.suppl_4.S3","volume":"61","author":"EI Eger","year":"2004","unstructured":"Eger EI (2004) Characteristics of anesthetic agents used for induction and maintenance of general anesthesia. Am J Health Syst Pharm 61(Suppl 4):S3\u2013S10","journal-title":"Am J Health Syst Pharm"},{"key":"1_CR43_1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1136\/bmj.306.6872.233","volume":"306","author":"CK Fairley","year":"1993","unstructured":"Fairley CK, McNeil JJ, Desmond P, Smallwood R, Young H, Forbes A, Purcell P, Boyd I (1993) Risk factors for development of flucloxacillin associated jaundice. BMJ 306:233\u2013235","journal-title":"BMJ"},{"key":"1_CR44_1","volume-title":"Drug-induced liver disease","author":"OC Farell","year":"1994","unstructured":"Farell OC (1994) Drug-induced liver disease. Churchill Livingstone, London"},{"key":"1_CR45_1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2165\/00002018-199716030-00002","volume":"16","author":"JP Fee","year":"1997","unstructured":"Fee JP, Thompson GH (1997) Comparative tolerability profiles of the inhaled anaesthetics. Drug Saf 16:157\u2013170","journal-title":"Drug Saf"},{"key":"1_CR46_1","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/lt.500050607","volume":"5","author":"RJ Fontana","year":"1999","unstructured":"Fontana RJ, McCashland TM, Benner KG, Appelman HD, Gunartanam NT, Wisecarver JL, Rabkin JM, Lee WM (1999) Acute liver failure associated with prolonged use of bromfenac leading to liver transplantation. The Acute Liver Failure Study Group. Liver Transpl Surg 5:480\u2013484","journal-title":"Liver Transpl Surg"},{"key":"1_CR47_1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.7326\/0003-4819-132-2-200001180-00005","volume":"132","author":"LM Forman","year":"2000","unstructured":"Forman LM, Simmons DA, Diamond RH (2000) Hepatic failure in a patient taking rosiglitazone. Ann Int Med 132:118\u2013121","journal-title":"Ann Int Med"},{"key":"1_CR48_1","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1124\/mol.59.3.627","volume":"59","author":"C Funk","year":"2001","unstructured":"Funk C, Ponelle C, Scheuermann G, Pantze M (2001) Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat. Mol Pharmacol 59:627\u2013635","journal-title":"Mol Pharmacol"},{"key":"1_CR49_1","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1016\/S0140-6736(00)04960-6","volume":"357","author":"EA Gale","year":"2001","unstructured":"Gale EA (2001) Lessons from the glitazones: a story of drug development. Lancet 357: 1870\u20131875","journal-title":"Lancet"},{"key":"1_CR50_1","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0022-3565(25)32241-X","volume":"214","author":"AJ Gandolfi","year":"1980","unstructured":"Gandolfi AJ, White RD, Sipes IG, Pohl LR (1980) Bioactivation and covalent binding of halothane in vitro: studies with [3H]- and [14C]halothane. J Pharmacol Exp Ther 214:721\u2013725","journal-title":"J Pharmacol Exp Ther"},{"key":"1_CR51_1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0300-483X(01)00523-6","volume":"169","author":"PE Ganey","year":"2001","unstructured":"Ganey PE, Roth RA (2001) Concurrent inflammation as a determinant of susceptibility to toxicity from xenobiotic agents. Toxicology 169:195\u2013208","journal-title":"Toxicology"},{"key":"1_CR52_1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00000542-196301000-00005","volume":"24","author":"Brody GL","year":"1963","unstructured":"GL Brody, RB Sweet (1963) Halothane anesthesia as a possible cause of massive hepatic necrosis. Anesthesiology 24:29\u201337","journal-title":"Anesthesiology"},{"key":"1_CR53_1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0002-9343(02)01529-2","volume":"114","author":"DJ Graham","year":"2003","unstructured":"Graham DJ, Green L, Senior JR, Nourjah P (2003) Troglitazone-induced liver failure: a case study. Am J Med 114:299\u2013306","journal-title":"Am J Med"},{"key":"1_CR54_1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2125.1995.tb04470.x","volume":"39","author":"VJ Green","year":"1995","unstructured":"Green VJ, Pirmohamed M, Kitteringham NR, Knapp MJ, Park BK (1995) Glutathione S-transferase mu genotype (GSTM1*0) in Alzheimer's patients with tacrine transaminitis. Br J Clin Pharmacol 39:411\u2013415","journal-title":"Br J Clin Pharmacol"},{"key":"1_CR55_1","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/00498250500137427","volume":"35","author":"K Gross-Steinmeyer","year":"2005","unstructured":"Gross-Steinmeyer K, Stapleton PL, Tracy JH, Bammler TK, Lehman T, Strom SC, Eaton DL (2005) Influence of Matrigel-overlay on constitutive and inducible expression of nine genes encoding drug-metabolizing enzymes in primary human hepatocytes. Xenobiotica 35:419\u2013438","journal-title":"Xenobiotica"},{"key":"1_CR56_1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1081\/DMR-120034148","volume":"36","author":"B Gunawan","year":"2004","unstructured":"Gunawan B, Kaplowitz N (2004) Clinical perspectives on xenobiotic-induced hepatotoxicity. Drug Metab Rev 36:301\u2013312","journal-title":"Drug Metab Rev"},{"key":"1_CR57_1","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/j.1432-1033.1992.tb17456.x","volume":"210","author":"J Gut","year":"1992","unstructured":"Gut J, Christen U, Huwyler J, Burgin M, Kenna JG (1992) Molecular mimicry of trifluoroacetylated human liver protein adducts by constitutive proteins and immunochemical evidence for its impairment in halothane hepatitis. Eur J Biochem 210:569\u2013576","journal-title":"Eur J Biochem"},{"key":"1_CR58_1","first-page":"CR292","volume":"8","author":"M Hartleb","year":"2002","unstructured":"Hartleb M, Biernat L, Kochel A (2002) Drug-induced liver damage \u2013 a three-year study of patients from one gastroenterological department. Med Sci Monit 8:CR292\u2013CR296","journal-title":"Med Sci Monit"},{"key":"1_CR59_1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0006-2952(01)00653-0","volume":"62","author":"K He","year":"2001","unstructured":"He K, Woolf TF, Kindt EK, Fielder AE, Talaat RE (2001) Troglitazone quinone formation catalyzed by human and rat CYP3A: an atypical CYP oxidation reaction. Biochem Pharmacol 62:191\u2013198","journal-title":"Biochem Pharmacol"},{"key":"1_CR60_1","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1023\/B:PHAM.0000033018.97745.0d","volume":"21","author":"KA Hoffmaster","year":"2004","unstructured":"Hoffmaster KA, Turncliff RZ, LeCluyse EL, Kim RB, Meier PJ, Brouwer KL (2004) P-glycoprotein expression, localization, and function in sandwich-cultured primary rat and human hepatocytes: relevance to the hepatobiliary disposition of a model opioid peptide. Pharm Res 21:1294\u20131302","journal-title":"Pharm Res"},{"issue":"106","key":"1_CR61_1","first-page":"110","volume":"162","author":"V Hogan","year":"2000","unstructured":"Hogan V (2000) Pemoline (Cylert): market withdrawal. CMAJ 162(106):110","journal-title":"CMAJ"},{"key":"1_CR62_1","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1053\/jhep.2003.50144","volume":"37","author":"YS Huang","year":"2003","unstructured":"Huang YS, Chern HD, Su WJ, Wu JC, Chang SC, Chiang CH, Chang FY, Lee SD (2003) Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis. Hepatology 37:924\u2013930","journal-title":"Hepatology"},{"key":"1_CR63_1","unstructured":"Igarashi (1994) The duration of toxicity studies required to support repeated dosing in clinical investigation--A toxicologists opinion. In: Parkinson C, McAuslane N, Lumley C, Waler SR (eds) CMR Workshop: the timing of toxicological studies to support clinical trials. Kluwer, Boston, pp 67\u201374"},{"key":"1_CR64_1","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1096\/fj.02-0046com","volume":"16","author":"Y Ishida","year":"2002","unstructured":"Ishida Y, Kondo T, Ohshima T, Fujiwara H, Iwakura Y, Mukaida N (2002) A pivotal involvement of IFN-gamma in the pathogenesis of acetaminophen-induced acute liver injury. FASEB J 16:1227\u20131236","journal-title":"FASEB J"},{"key":"1_CR65_1","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1002\/eji.200535261","volume":"36","author":"Y Ishida","year":"2006","unstructured":"Ishida Y, Kondo T, Kimura A, Tsuneyama K, Takayasu T, Mukaida N (2006) Opposite roles of neutrophils and macrophages in the pathogenesis of acetaminophen-induced acute liver injury. Eur J Immunol 36:1028\u20131038","journal-title":"Eur J Immunol"},{"key":"1_CR66_1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","volume":"20","author":"CA Janeway Jr","year":"2002","unstructured":"Janeway CA Jr, Medzhitov R (2002) Innate immune recognition. Annu Rev Immunol 20:197\u2013216","journal-title":"Annu Rev Immunol"},{"key":"1_CR67_1","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0041-008X(80)90114-3","volume":"52","author":"RC Jee","year":"1980","unstructured":"Jee RC, Sipes IG, Gandolfi AJ, Brown BR Jr (1980) Factors influencing halothane hepatotoxicity in the rat hypoxic model. Toxicol Appl Pharmacol 52:267\u2013277","journal-title":"Toxicol Appl Pharmacol"},{"key":"1_CR68_1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.tox.2004.12.017","volume":"209","author":"C Ju","year":"2005","unstructured":"Ju C, Pohl LR (2005) Tolerogenic role of Kupffer cells in immune-mediated adverse drug reactions. Toxicology 209:109\u2013112","journal-title":"Toxicology"},{"key":"1_CR69_1","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1021\/tx0255976","volume":"15","author":"C Ju","year":"2002","unstructured":"Ju C, Reilly TP, Bourdi M, Radonovich MF, Brady JN, George JW, Pohl LR (2002) Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice. Chem Res Toxicol 15:1504\u20131513","journal-title":"Chem Res Toxicol"},{"key":"1_CR70_1","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1021\/tx0341761","volume":"16","author":"C Ju","year":"2003","unstructured":"Ju C, McCoy JP, Chung CJ, Graf ML, Pohl LR (2003) Tolerogenic role of Kupffer cells in allergic reactions. Chem Res Toxicol 16:1514\u20131519","journal-title":"Chem Res Toxicol"},{"key":"1_CR71_1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1124\/dmd.104.001735","volume":"33","author":"AS Kalgutkar","year":"2005","unstructured":"Kalgutkar AS, Vaz AD, Lame ME, Henne KR, Soglia J, Zhao SX, Abramov YA, Lombardo F, Collin C, Hendsch ZS, Hop CE (2005) Bioactivation of the nontricyclic antidepressant nefazodone to a reactive quinone-imine species in human liver microsomes and recombinant cytochrome P450 3A4. Drug Metab Dispos 33:243\u2013253","journal-title":"Drug Metab Dispos"},{"key":"1_CR72_1","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2165\/00002018-200124070-00001","volume":"24","author":"N Kaplowitz","year":"2001","unstructured":"Kaplowitz N (2001) Drug-induced liver disorders: implications for drug development and regulation. Drug Saf 24:483\u2013490","journal-title":"Drug Saf"},{"key":"1_CR73_1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1021\/tx000180q","volume":"14","author":"K Kassahun","year":"2001","unstructured":"Kassahun K, Pearson PG, Tang W, McIntosh I, Leung K, Elmore C, Dean D, Wang R, Doss G, Baillie TA (2001) Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission. Chem Res Toxicol 14:62\u201370","journal-title":"Chem Res Toxicol"},{"key":"1_CR74_1","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1136\/bmj.294.6581.1209","volume":"294","author":"JG Kenna","year":"1987","unstructured":"Kenna JG, Neuberger J, Mieli-Vergani G, Mowat AP, Williams R (1987) Halothane hepatitis in children. Br Med J (Clin Res Ed) 294:1209\u20131211","journal-title":"Br Med J (Clin Res Ed)"},{"key":"1_CR75_1","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0022-3565(25)24104-0","volume":"245","author":"JG Kenna","year":"1988","unstructured":"Kenna JG, Satoh H, Christ DD, Pohl LR (1988) Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane. J Pharmacol Exp Ther 245:1103\u20131109","journal-title":"J Pharmacol Exp Ther"},{"key":"1_CR76_1","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/clpt.2008.97","volume":"84","author":"ED Kharasch","year":"2008","unstructured":"Kharasch ED (2008) Adverse drug reactions with halogenated anesthetics. Clin Pharmacol Ther 84:158\u2013162","journal-title":"Clin Pharmacol Ther"},{"key":"1_CR77_1","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/S0016-5085(99)70508-1","volume":"116","author":"PA Knolle","year":"1999","unstructured":"Knolle PA, Schmitt E, Jin S, Germann T, Duchmann R, Hegenbarth S, Gerken G, Lohse AW (1999) Induction of cytokine production in naive CD4(+) T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells. Gastroenterology 116:1428\u20131440","journal-title":"Gastroenterology"},{"key":"1_CR78_1","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1021\/bi9823030","volume":"38","author":"LL Koenigs","year":"1999","unstructured":"Koenigs LL, Peter RM, Hunter AP, Haining RL, Rettie AE, Friedberg T, Pritchard MP, Shou M, Rushmore TH, Trager WF (1999) Electrospray ionization mass spectrometric analysis of intact cytochrome P450: identification of tienilic acid adducts to P450 2C9. Biochemistry 38:2312\u20132319","journal-title":"Biochemistry"},{"key":"1_CR79_1","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1002\/hep.22272","volume":"47","author":"C Lammert","year":"2008","unstructured":"Lammert C, Einarsson S, Saha C, Niklasson A, Bjornsson E, Chalasani N (2008) Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals. Hepatology 47:2003\u20132009","journal-title":"Hepatology"},{"key":"1_CR80_1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0168-8278(00)80417-1","volume":"32","author":"D Larrey","year":"2000","unstructured":"Larrey D (2000) Drug-induced liver diseases. J Hepatol 32:77\u201388","journal-title":"J Hepatol"},{"key":"1_CR81_1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1055\/s-2002-30101","volume":"22","author":"D Larrey","year":"2002","unstructured":"Larrey D (2002) Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Semin Liver Dis 22:145\u2013155","journal-title":"Semin Liver Dis"},{"key":"1_CR82_1","unstructured":"Laskin, Gardner CR (2003) Nonparenchymal cells, inflammatory macrophages, and hepatotoxicity. Drug-induced liver diseases. Marcel Dekker, New York, pp 183\u2013212"},{"key":"1_CR83_1","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1002\/hep.1840210424","volume":"21","author":"DL Laskin","year":"1995","unstructured":"Laskin DL, Gardner CR, Price VF, Jollow DJ (1995) Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen. Hepatology 21:1045\u20131050","journal-title":"Hepatology"},{"key":"1_CR84_1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/toxsci\/54.2.509","volume":"54","author":"JA Lawson","year":"2000","unstructured":"Lawson JA, Farhood A, Hopper RD, Bajt ML, Jaeschke H (2000) The hepatic inflammatory response after acetaminophen overdose: role of neutrophils. Toxicol Sci 54:509\u2013516","journal-title":"Toxicol Sci"},{"key":"1_CR85_1","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","volume":"279","author":"J Lazarou","year":"1998","unstructured":"Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279:1200\u20131205","journal-title":"JAMA"},{"key":"1_CR86_1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/01.mog.0000160043.10804.60","volume":"21","author":"SK Lazerow","year":"2005","unstructured":"Lazerow SK, Abdi MS, Lewis JH (2005) Drug-induced liver disease 2004. Curr Opin Gastroenterol 21:283\u2013292","journal-title":"Curr Opin Gastroenterol"},{"key":"1_CR87_1","first-page":"207","volume":"290","author":"EL LeCluyse","year":"2005","unstructured":"LeCluyse EL, Alexandre E, Hamilton GA, Viollon-Abadie C, Coon DJ, Jolley S, Richert L (2005) Isolation and culture of primary human hepatocytes. Methods Mol Biol 290:207\u2013229","journal-title":"Methods Mol Biol"},{"key":"1_CR88_1","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0026-895X(25)09234-X","volume":"50","author":"S Lecoeur","year":"1996","unstructured":"Lecoeur S, Andre C, Beaune PH (1996) Tienilic acid-induced autoimmune hepatitis: anti-liver and-kidney microsomal type 2 autoantibodies recognize a three-site conformational epitope on cytochrome P4502C9. Mol Pharmacol 50:326\u2013333","journal-title":"Mol Pharmacol"},{"key":"1_CR89_1","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1056\/NEJMra021844","volume":"349","author":"WM Lee","year":"2003","unstructured":"Lee WM (2003) Drug-induced hepatotoxicity. N Engl J Med 349:474\u2013485","journal-title":"N Engl J Med"},{"key":"1_CR90_1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/01926230590522356","volume":"33","author":"WM Lee","year":"2005","unstructured":"Lee WM, Senior JR (2005) Recognizing drug-induced liver injury: current problems, possible solutions. Toxicol Pathol 33:155\u2013164","journal-title":"Toxicol Pathol"},{"key":"1_CR91_1","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/82161","volume":"6","author":"A Limmer","year":"2000","unstructured":"Limmer A, Ohl J, Kurts C, Ljunggren HG, Reiss Y, Groettrup M, Momburg F, Arnold B, Knolle PA (2000) Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat Med 6:1348\u20131354","journal-title":"Nat Med"},{"key":"1_CR92_1","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1097\/00000542-198912000-00011","volume":"71","author":"RC Lind","year":"1989","unstructured":"Lind RC, Gandolfi AJ, Hall PD (1989a) Age and gender influence halothane-associated hepatotoxicity in strain 13 guinea pigs. Anesthesiology 71:878\u2013884","journal-title":"Anesthesiology"},{"key":"1_CR93_1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000542-198904000-00018","volume":"70","author":"RC Lind","year":"1989","unstructured":"Lind RC, Gandolfi AJ, Hall PD (1989b) The role of oxidative biotransformation of halothane in the guinea pig model of halothane-associated hepatotoxicity. Anesthesiology 70:649\u2013653","journal-title":"Anesthesiology"},{"key":"1_CR94_1","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1097\/00000542-199012000-00019","volume":"73","author":"RC Lind","year":"1990","unstructured":"Lind RC, Gandolfi AJ, Hall PD (1990) Covalent binding of oxidative biotransformation intermediates is associated with halothane hepatotoxicity in guinea pigs. Anesthesiology 73:1208\u20131213","journal-title":"Anesthesiology"},{"key":"1_CR95_1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1056\/NEJM196303072681004","volume":"268","author":"J Lindenbaum","year":"1963","unstructured":"Lindenbaum J, Leifer E (1963) Hepatic necrosis associated with halothane anesthesia. N Engl J Med 268:525\u2013530","journal-title":"N Engl J Med"},{"key":"1_CR96_1","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S1089-3261(02)00025-9","volume":"6","author":"ZX Liu","year":"2002","unstructured":"Liu ZX, Kaplowitz N (2002) Immune-mediated drug-induced liver disease. Clin Liver Dis 6:755\u2013774","journal-title":"Clin Liver Dis"},{"key":"1_CR97_1","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1053\/j.gastro.2004.08.053","volume":"127","author":"ZX Liu","year":"2004","unstructured":"Liu ZX, Govindarajan S, Kaplowitz N (2004) Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. Gastroenterology 127:1760\u20131774","journal-title":"Gastroenterology"},{"key":"1_CR98_1","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1002\/hep.21175","volume":"43","author":"ZX Liu","year":"2006","unstructured":"Liu ZX, Han D, Gunawan B, Kaplowitz N (2006) Neutrophil depletion protects against murine acetaminophen hepatotoxicity. Hepatology 43:1220\u20131230","journal-title":"Hepatology"},{"key":"1_CR99_1","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/j.1552-4604.1997.tb04285.x","volume":"37","author":"CM Loi","year":"1997","unstructured":"Loi CM, Alvey CW, Randinitis EJ, Abel R, Young MA, Koup JR (1997) Meta-analysis of steady-state pharmacokinetics of troglitazone and its metabolites. J Clin Pharmacol 37:1038\u20131047","journal-title":"J Clin Pharmacol"},{"key":"1_CR100_1","unstructured":"Lumley (1990) Clinical toxicity: could it have been prevented? Premarketing experience. In: Lumley CE, Walker SW (eds) CMR workshop \u2013 animal toxicity studies: their relevance for man. Quay, Lancaster, UK, pp 49\u201356"},{"key":"1_CR101_1","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0022-3565(25)20918-1","volume":"232","author":"CA Lunam","year":"1985","unstructured":"Lunam CA, Cousins MJ, Hall PD (1985) Guinea-pig model of halothane-associated hepatotoxicity in the absence of enzyme induction and hypoxia. J Pharmacol Exp Ther 232:802\u2013809","journal-title":"J Pharmacol Exp Ther"},{"key":"1_CR102_1","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0378-4274(01)00284-3","volume":"120","author":"MI Luster","year":"2001","unstructured":"Luster MI, Simeonova PP, Gallucci RM, Bruccoleri A, Blazka ME, Yucesoy B (2001) Role of inflammation in chemical-induced hepatotoxicity. Toxicol Lett 120:317\u2013321","journal-title":"Toxicol Lett"},{"key":"1_CR103_1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0140-6736(02)07873-X","volume":"359","author":"S Mallal","year":"2002","unstructured":"Mallal S, Nolan D, Witt C, Masel G, Martin AM, Moore C, Sayer D, Castley A, Mamotte C, Maxwell D, James I, Christiansen FT (2002) Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet 359:727\u2013732","journal-title":"Lancet"},{"key":"1_CR104_1","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/hep.22400","volume":"48","author":"MJ Masson","year":"2008","unstructured":"Masson MJ, Carpenter LD, Graf ML, Pohl LR (2008) Pathogenic role of natural killer T and natural killer cells in acetaminophen-induced liver injury in mice is dependent on the presence of dimethyl sulfoxide. Hepatology 48:889\u2013897","journal-title":"Hepatology"},{"key":"1_CR105_1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0006-291X(03)00572-2","volume":"304","author":"Y Masubuchi","year":"2003","unstructured":"Masubuchi Y, Bourdi M, Reilly TP, Graf ML, George JW, Pohl LR (2003) Role of interleukin-6 in hepatic heat shock protein expression and protection against acetaminophen-induced liver disease. Biochem Biophys Res Commun 304:207\u2013212","journal-title":"Biochem Biophys Res Commun"},{"key":"1_CR106_1","doi-asserted-by":"crossref","first-page":"449","DOI":"10.7326\/0003-4819-136-6-200203190-00008","volume":"136","author":"LD May","year":"2002","unstructured":"May LD, Lefkowitch JH, Kram MT, Rubin DE (2002) Mixed hepatocellular-cholestatic liver injury after pioglitazone therapy. Ann Int Med 136:449\u2013452","journal-title":"Ann Int Med"},{"key":"1_CR107_1","first-page":"214","volume":"26","author":"H McKenzie","year":"1976","unstructured":"McKenzie H, Parratt D, White RG (1976) IgM and IgG antibody levels to ampicillin in patients with infectious mononucleosis. Clin Exp Immunol 26:214\u2013221","journal-title":"Clin Exp Immunol"},{"key":"1_CR108_1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/00000542-197910000-00008","volume":"51","author":"GE McLain","year":"1979","unstructured":"McLain GE, Sipes IG, Brown BR Jr (1979) An animal model of halothane hepatotoxicity: roles of enzyme induction and hypoxia. Anesthesiology 51:321\u2013326","journal-title":"Anesthesiology"},{"key":"1_CR109_1","first-page":"8","volume":"35","author":"M Meadows","year":"2001","unstructured":"Meadows M (2001) Serious liver injury. Leading reason for drug removals, restrictions. FDA Consum 35:8\u20139","journal-title":"FDA Consum"},{"key":"1_CR110_1","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/hep.510300104","volume":"30","author":"SL Michael","year":"1999","unstructured":"Michael SL, Pumford NR, Mayeux PR, Niesman MR, Hinson JA (1999) Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species. Hepatology 30:186\u2013195","journal-title":"Hepatology"},{"key":"1_CR111_1","doi-asserted-by":"crossref","first-page":"799","DOI":"10.7326\/0003-4819-113-10-799","volume":"113","author":"R Murphy","year":"1990","unstructured":"Murphy R, Swartz R, Watkins PB (1990) Severe acetaminophen toxicity in a patient receiving isoniazid. Ann Int Med 113:799\u2013800","journal-title":"Ann Int Med"},{"key":"1_CR112_1","doi-asserted-by":"crossref","first-page":"5998","DOI":"10.4049\/jimmunol.164.11.5998","volume":"164","author":"M Muzio","year":"2000","unstructured":"Muzio M, Bosisio D, Polentarutti N, D'amico G, Stoppacciaro A, Mancinelli R, van't Veer C, Penton-Rol G, Ruco LP, Allavena P, Mantovani A (2000) Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 164:5998\u20136004","journal-title":"J Immunol"},{"key":"1_CR113_1","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1124\/mol.63.3.732","volume":"63","author":"DJ Naisbitt","year":"2003","unstructured":"Naisbitt DJ, Britschgi M, Wong G, Farrell J, Depta JP, Chadwick DW, Pichler WJ, Pirmohamed M, Park BK (2003a) Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones. Mol Pharmacol 63:732\u2013741","journal-title":"Mol Pharmacol"},{"key":"1_CR114_1","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1067\/mai.2003.1507","volume":"111","author":"DJ Naisbitt","year":"2003","unstructured":"Naisbitt DJ, Farrell J, Wong G, Depta JP, Dodd CC, Hopkins JE, Gibney CA, Chadwick DW, Pichler WJ, Pirmohamed M, Park BK (2003b) Characterization of drug-specific T cells in lamotrigine hypersensitivity. J Allerg Clin Immunol 111:1393\u20131403","journal-title":"J Allerg Clin Immunol"},{"key":"1_CR115_1","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0022-3565(25)31362-5","volume":"206","author":"SD Nelson","year":"1978","unstructured":"Nelson SD, Mitchell JR, Snodgrass WR, Timbrell JA (1978) Hepatotoxicity and metabolism of iproniazid and isopropylhydrazine. J Pharmacol Exp Ther 206:574\u2013585","journal-title":"J Pharmacol Exp Ther"},{"key":"1_CR116_1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2165\/00002018-199005010-00004","volume":"5","author":"JM Neuberger","year":"1990","unstructured":"Neuberger JM (1990) Halothane and hepatitis. Incidence, predisposing factors and exposure guidelines. Drug Saf 5:28\u201338","journal-title":"Drug Saf"},{"key":"1_CR117_1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1042\/cs0720263","volume":"72","author":"J Neuberger","year":"1987","unstructured":"Neuberger J, Kenna JG (1987) Halothane hepatitis: a model of immune mediated drug hepatotoxicity. Clin Sci (Lond) 72:263\u2013270","journal-title":"Clin Sci (Lond)"},{"key":"1_CR118_1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1213\/00000539-199701000-00031","volume":"84","author":"D Njoku","year":"1997","unstructured":"Njoku D, Laster MJ, Gong DH, Eger EI, Reed GF, Martin JL (1997) Biotransformation of halothane, enflurane, isoflurane, and desflurane to trifluoroacetylated liver proteins: association between protein acylation and hepatic injury. Anesth Analg 84:173\u2013178","journal-title":"Anesth Analg"},{"key":"1_CR119_1","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1136\/gut.47.5.717","volume":"47","author":"J O'Donohue","year":"2000","unstructured":"O'Donohue J, Oien KA, Donaldson P, Underhill J, Clare M, MacSween RN, Mills PR (2000) Co-amoxiclav jaundice: clinical and histological features and HLA class II association. Gut 47:717\u2013720","journal-title":"Gut"},{"key":"1_CR120_1","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1046\/j.1440-1746.2000.02074.x","volume":"15","author":"G Ostapowicz","year":"2000","unstructured":"Ostapowicz G, Lee WM (2000) Acute hepatic failure: a Western perspective. J Gastroenterol Hepatol 15:480\u2013488","journal-title":"J Gastroenterol Hepatol"},{"key":"1_CR121_1","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","volume":"137","author":"G Ostapowicz","year":"2002","unstructured":"Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH, McCashland TM, Shakil AO, Hay JE, Hynan L, Crippin JS, Blei AT, Samuel G, Reisch J, Lee WM (2002) Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Int Med 137:947\u2013954","journal-title":"Ann Int Med"},{"key":"1_CR122_1","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1021\/tx980058f","volume":"11","author":"BK Park","year":"1998","unstructured":"Park BK, Pirmohamed M, Kitteringham NR (1998) Role of drug disposition in drug hypersensitivity: a chemical, molecular, and clinical perspective. Chem Res Toxicol 11:969\u2013988","journal-title":"Chem Res Toxicol"},{"key":"1_CR123_1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0300-483X(00)00303-6","volume":"153","author":"BK Park","year":"2000","unstructured":"Park BK, Kitteringham NR, Powell H, Pirmohamed M (2000) Advances in molecular toxicology-towards understanding idiosyncratic drug toxicity. Toxicology 153:39\u201360","journal-title":"Toxicology"},{"key":"1_CR124_1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1042\/bj2490495","volume":"249","author":"MC Peitsch","year":"1988","unstructured":"Peitsch MC, Tschopp J, Kress A, Isliker H (1988) Antibody-independent activation of the complement system by mitochondria is mediated by cardiolipin. Biochem J 249:495\u2013500","journal-title":"Biochem J"},{"key":"1_CR125_1","first-page":"1261","volume-title":"Oxford textbook of clinical hepatology","author":"LD Pessayre","year":"1999","unstructured":"Pessayre LD, Biour M (1999) Drug-induced liver injury. In: Bircher J, Benhamou JP, McIntyre N, Ruzzettim M, Rodes J (eds) Oxford textbook of clinical hepatology, 2nd edn. Oxford University Press, Oxford, pp 1261\u20131315","edition":"2"},{"key":"1_CR126_1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/00130832-200208000-00003","volume":"2","author":"WJ Pichler","year":"2002","unstructured":"Pichler WJ (2002) Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept. Curr Opin Allerg Clin Immunol 2:301\u2013305","journal-title":"Curr Opin Allerg Clin Immunol"},{"key":"1_CR127_1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.tox.2004.12.014","volume":"209","author":"WJ Pichler","year":"2005","unstructured":"Pichler WJ (2005) Direct T-cell stimulations by drugs\u2013bypassing the innate immune system. Toxicology 209:95\u2013100","journal-title":"Toxicology"},{"key":"1_CR128_1","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.4049\/jimmunol.172.2.1009","volume":"172","author":"VG Pillarisetty","year":"2004","unstructured":"Pillarisetty VG, Shah AB, Miller G, Bleier JI, DeMatteo RP (2004) Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition. J Immunol 172:1009\u20131017","journal-title":"J Immunol"},{"key":"1_CR129_1","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1146\/annurev.pa.28.040188.002055","volume":"28","author":"LR Pohl","year":"1988","unstructured":"Pohl LR, Satoh H, Christ DD, Kenna JG (1988) The immunologic and metabolic basis of drug hypersensitivities. Annu Rev Pharmacol Toxicol 28:367\u2013387","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1_CR130_1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3109\/03602538909103537","volume":"20","author":"LR Pohl","year":"1989","unstructured":"Pohl LR, Kenna JG, Satoh H, Christ D, Martin JL (1989) Neoantigens associated with halothane hepatitis. Drug Metab Rev 20:203\u2013217","journal-title":"Drug Metab Rev"},{"key":"1_CR131_1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1365-2893.2002.00326.x","volume":"9","author":"S Pol","year":"2002","unstructured":"Pol S, Vallet-Pichard A, Fontaine H (2002) Hepatitis C and human immune deficiency coinfection at the era of highly active antiretroviral therapy. J Viral Hepat 9:1\u20138","journal-title":"J Viral Hepat"},{"key":"1_CR132_1","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/S0140-6736(67)91893-4","volume":"2","author":"H Pullen","year":"1967","unstructured":"Pullen H, Wright N, Murdoch JM (1967) Hypersensitivity reactions to antibacterial drugs in infectious mononucleosis. Lancet 2:1176\u20131178","journal-title":"Lancet"},{"key":"1_CR133_1","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1345\/aph.18364","volume":"33","author":"JM Rabkin","year":"1999","unstructured":"Rabkin JM, Smith MJ, Orloff SL, Corless CL, Stenzel P, Olyaei AJ (1999) Fatal fulminant hepatitis associated with bromfenac use. Ann Pharmacother 33:945\u2013947","journal-title":"Ann Pharmacother"},{"key":"1_CR134_1","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1021\/tx0155505","volume":"14","author":"TP Reilly","year":"2001","unstructured":"Reilly TP, Brady JN, Marchick MR, Bourdi M, George JW, Radonovich MF, Pise-Masison CA, Pohl LR (2001) A protective role for cyclooxygenase-2 in drug-induced liver injury in mice. Chem Res Toxicol 14:1620\u20131628","journal-title":"Chem Res Toxicol"},{"key":"1_CR135_1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/00000542-197910000-00009","volume":"51","author":"WT Ross Jr","year":"1979","unstructured":"Ross WT Jr, Daggy BP, Cardell RR Jr (1979) Hepatic necrosis caused by halothane and hypoxia in phenobarbital-treated rats. Anesthesiology 51:327\u2013333","journal-title":"Anesthesiology"},{"key":"1_CR136_1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.102.041624","volume":"307","author":"RA Roth","year":"2003","unstructured":"Roth RA, Luyendyk JP, Maddox JF, Ganey PE (2003) Inflammation and drug idiosyncrasy\u2013is there a connection? J Pharmacol Exp Ther 307:1\u20138","journal-title":"J Pharmacol Exp Ther"},{"key":"1_CR137_1","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/lt.20204","volume":"10","author":"MW Russo","year":"2004","unstructured":"Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P (2004) Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl 10:1018\u20131023","journal-title":"Liver Transpl"},{"key":"1_CR138_1","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1097\/00004583-200106000-00006","volume":"40","author":"DJ Safer","year":"2001","unstructured":"Safer DJ, Zito JM, Gardner JE (2001) Pemoline hepatotoxicity and postmarketing surveillance. J Am Acad Child Adolesc Psychiatry 40:622\u2013629","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1_CR139_1","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0026-895X(25)14180-1","volume":"28","author":"H Satoh","year":"1985","unstructured":"Satoh H, Gillette JR, Davies HW, Schulick RD, Pohl LR (1985) Immunochemical evidence of trifluoroacetylated cytochrome P-450 in the liver of halothane-treated rats. Mol Pharmacol 28:468\u2013474","journal-title":"Mol Pharmacol"},{"key":"1_CR140_1","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1073\/pnas.86.1.322","volume":"86","author":"H Satoh","year":"1989","unstructured":"Satoh H, Martin BM, Schulick AH, Christ DD, Kenna JG, Pohl LR (1989) Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesterase. Proc Natl Acad Sci USA 86:322\u2013326","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR141_1","doi-asserted-by":"publisher","first-page":"313","DOI":"10.4088\/JCP.v59n0607","volume":"59","author":"AJ Saxon","year":"1998","unstructured":"Saxon AJ, Sloan KL, Reoux J, Haver VM (1998) Disulfiram use in patients with abnormal liver function test results. J Clin Psychiatry 59:313\u2013316","journal-title":"J Clin Psychiatry"},{"key":"1_CR142_1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1172\/JCI119505","volume":"100","author":"B Schnyder","year":"1997","unstructured":"Schnyder B, Mauri-Hellweg D, Zanni M, Bettens F, Pichler WJ (1997) Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones. J Clin Invest 100:136\u2013141","journal-title":"J Clin Invest"},{"key":"1_CR143_1","doi-asserted-by":"crossref","first-page":"6647","DOI":"10.4049\/jimmunol.164.12.6647","volume":"164","author":"B Schnyder","year":"2000","unstructured":"Schnyder B, Burkhart C, Schnyder-Frutig K, von Greyerz S, Naisbitt DJ, Pirmohamed M, Park BK, Pichler WJ (2000) Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals. J Immunol 164:6647\u20136654","journal-title":"J Immunol"},{"key":"1_CR144_1","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nri1372","volume":"4","author":"SY Seong","year":"2004","unstructured":"Seong SY, Matzinger P (2004) Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 4:469\u2013478","journal-title":"Nat Rev Immunol"},{"key":"1_CR145_1","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1053\/jhep.2002.34857","volume":"36","author":"C Sgro","year":"2002","unstructured":"Sgro C, Clinard F, Ouazir K, Chanay H, Allard C, Guilleminet C, Lenoir C, Lemoine A, Hillon P (2002) Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology 36:451\u2013455","journal-title":"Hepatology"},{"key":"1_CR146_1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0887-8994(96)00266-4","volume":"16","author":"M Shevell","year":"1997","unstructured":"Shevell M, Schreiber R (1997) Pemoline-associated hepatic failure: a critical analysis of the literature. Pediatr Neurol 16:14\u201316","journal-title":"Pediatr Neurol"},{"key":"1_CR147_1","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/nature01991","volume":"425","author":"Y Shi","year":"2003","unstructured":"Shi Y, Evans JE, Rock KL (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425:516\u2013521","journal-title":"Nature"},{"key":"1_CR148_1","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1006\/jsre.1998.5441","volume":"80","author":"GS Smith","year":"1998","unstructured":"Smith GS, Nadig DE, Kokoska ER, Solomon H, Tiniakos DG, Miller TA (1998) Role of neutrophils in hepatotoxicity induced by oral acetaminophen administration in rats. J Surg Res 80:252\u2013258","journal-title":"J Surg Res"},{"key":"1_CR149_1","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0022-3565(24)36603-0","volume":"281","author":"DK Spracklin","year":"1997","unstructured":"Spracklin DK, Hankins DC, Fisher JM, Thummel KE, Kharasch ED (1997) Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro. J Pharmacol Exp Ther 281:400\u2013411","journal-title":"J Pharmacol Exp Ther"},{"key":"1_CR150_1","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2146\/ajhp050460","volume":"63","author":"J Stachnik","year":"2006","unstructured":"Stachnik J (2006) Inhaled anesthetic agents. Am J Health Syst Pharm 63:623\u2013634","journal-title":"Am J Health Syst Pharm"},{"key":"1_CR151_1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/070674370204700409","volume":"47","author":"DE Stewart","year":"2002","unstructured":"Stewart DE (2002) Hepatic adverse reactions associated with nefazodone. Can J Psychiatry 47:375\u2013377","journal-title":"Can J Psychiatry"},{"key":"1_CR152_1","unstructured":"Stricker (1992) Drug-induced hepatic injury. In: Dukes M (ed) Drug-induced disorders, 2nd edn. Elviser, Amsterdam, pp 210\u2013240"},{"key":"1_CR153_1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1001\/jama.283.1.74","volume":"283","author":"MS Sulkowski","year":"2000","unstructured":"Sulkowski MS, Thomas DL, Chaisson RE, Moore RD (2000) Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA 283:74\u201380","journal-title":"JAMA"},{"key":"1_CR154_1","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1124\/dmd.108.021725","volume":"36","author":"H Takakusa","year":"2008","unstructured":"Takakusa H, Masumoto H, Yukinaga H, Makino C, Nakayama S, Okazaki O, Sudo K (2008) Covalent binding and tissue distribution\/retention assessment of drugs associated with idiosyncratic drug toxicity. Drug Metab Dispos 36:1770\u20131779","journal-title":"Drug Metab Dispos"},{"key":"1_CR155_1","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1001\/jama.287.17.2273","volume":"287","author":"RJ Temple","year":"2002","unstructured":"Temple RJ, Himmel MH (2002) Safety of newly approved drugs: implications for prescribing. JAMA 287:2273\u20132275","journal-title":"JAMA"},{"key":"1_CR156_1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1084\/jem.20001858","volume":"195","author":"C Termeer","year":"2002","unstructured":"Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C, Simon JC (2002) Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 195:99\u2013111","journal-title":"J Exp Med"},{"key":"1_CR157_1","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1021\/tx0001981","volume":"14","author":"JN Tettey","year":"2001","unstructured":"Tettey JN, Maggs JL, Rapeport WG, Pirmohamed M, Park BK (2001) Enzyme-induction dependent bioactivation of troglitazone and troglitazone quinone in vivo. Chem Res Toxicol 14:965\u2013974","journal-title":"Chem Res Toxicol"},{"key":"1_CR158_1","doi-asserted-by":"publisher","first-page":"13S","DOI":"10.1016\/S0002-9343(98)00070-9","volume":"105","author":"KG Tolman","year":"1998","unstructured":"Tolman KG (1998) Hepatotoxicity of non-narcotic analgesics. Am J Med 105:13S\u201319S","journal-title":"Am J Med"},{"key":"1_CR159_1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1021\/tx980249i","volume":"12","author":"JP Uetrecht","year":"1999","unstructured":"Uetrecht JP (1999) New concepts in immunology relevant to idiosyncratic drug reactions: the \u201cdanger hypothesis\u201d and innate immune system. Chem Res Toxicol 12:387\u2013395","journal-title":"Chem Res Toxicol"},{"key":"1_CR160_1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1056\/NEJM198007103030202","volume":"303","author":"D Vergani","year":"1980","unstructured":"Vergani D, Mieli-Vergani G, Alberti A, Neuberger J, Eddleston AL, Davis M, Williams R (1980) Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. N Engl J Med 303:66\u201371","journal-title":"N Engl J Med"},{"key":"1_CR161_1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4049\/jimmunol.166.1.249","volume":"166","author":"A Visintin","year":"2001","unstructured":"Visintin A, Mazzoni A, Spitzer JH, Wyllie DH, Dower SK, Segal DM (2001) Regulation of Toll-like receptors in human monocytes and dendritic cells. J Immunol 166:249\u2013255","journal-title":"J Immunol"},{"key":"1_CR162_1","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S1471-4906(01)02168-8","volume":"23","author":"RP Wallin","year":"2002","unstructured":"Wallin RP, Lundqvist A, More SH, von Bonin A, Kiessling R, Ljunggren HG (2002) Heat-shock proteins as activators of the innate immune system. Trends Immunol 23:130\u2013135","journal-title":"Trends Immunol"},{"key":"1_CR163_1","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.4049\/jimmunol.160.3.1098","volume":"160","author":"M Wang","year":"1998","unstructured":"Wang M, Ellison CA, Gartner JG, HayGlass KT (1998) Natural killer cell depletion fails to influence initial CD4 T cell commitment in vivo in exogenous antigen-stimulated cytokine and antibody responses. J Immunol 160:1098\u20131105","journal-title":"J Immunol"},{"key":"1_CR164_1","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1124\/jpet.105.096347","volume":"316","author":"JF Waring","year":"2006","unstructured":"Waring JF, Liguori MJ, Luyendyk JP, Maddox JF, Ganey PE, Stachlewitz RF, North C, Blomme EA, Roth RA (2006) Microarray analysis of lipopolysaccharide potentiation of trovafloxacin-induced liver injury in rats suggests a role for proinflammatory chemokines and neutrophils. J Pharmacol Exp Ther 316:1080\u20131087","journal-title":"J Pharmacol Exp Ther"},{"key":"1_CR165_1","first-page":"838","volume":"63","author":"LO Warner","year":"1984","unstructured":"Warner LO, Beach TP, Garvin JP, Warner EJ (1984) Halothane and children: the first quarter century. Anesth Analg 63:838\u2013840","journal-title":"Anesth Analg"},{"key":"1_CR166_1","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/hep.21095","volume":"43","author":"PB Watkins","year":"2006","unstructured":"Watkins PB, Seeff LB (2006) Drug-induced liver injury: summary of a single topic clinical research conference. Hepatology 43:618\u2013631","journal-title":"Hepatology"},{"key":"1_CR167_1","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1056\/NEJM199803263381314","volume":"338","author":"PB Watkins","year":"1998","unstructured":"Watkins PB, Whitcomb RW (1998) Hepatic dysfunction associated with troglitazone. N Engl J Med 338:916\u2013917","journal-title":"N Engl J Med"},{"key":"1_CR168_1","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0140-6736(75)93000-7","volume":"1","author":"R Wright","year":"1975","unstructured":"Wright R, Eade OE, Chisholm M, Hawksley M, Lloyd B, Moles TM, Edwards JC, GArdner MJ (1975) Controlled prospective study of the effect on liver function of multiple exposures to halothane. Lancet 1:817\u2013820","journal-title":"Lancet"},{"key":"1_CR169_1","volume-title":"Cellular Imaging Predictions of Clinical Drug-Induced Liver Injury","author":"JJ Xu","year":"2008","unstructured":"Xu JJ, Henstock PV, Dunn MC, Smith AR, Chabot JR, de Graaf D (2008) Cellular Imaging Predictions of Clinical Drug-Induced Liver Injury. Toxicol, Sci"},{"key":"1_CR170_1","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1021\/tx600349f","volume":"20","author":"SB Yee","year":"2007","unstructured":"Yee SB, Bourdi M, Masson MJ, Pohl LR (2007) Hepatoprotective role of endogenous interleukin-13 in a murine model of acetaminophen-induced liver disease. Chem Res Toxicol 20:734\u2013744","journal-title":"Chem Res Toxicol"},{"key":"1_CR171_1","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/hep.21425","volume":"44","author":"Q You","year":"2006","unstructured":"You Q, Cheng L, Reilly TP, Wegmann D, Ju C (2006) Role of neutrophils in a mouse model of halothane-induced liver injury. Hepatology 44:1421\u20131431","journal-title":"Hepatology"},{"key":"1_CR172_1","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1002\/hep.22395","volume":"48","author":"Q You","year":"2008","unstructured":"You Q, Cheng L, Kedl RM, Ju C (2008) Mechanism of T cell tolerance induction by murine hepatic Kupffer cells. Hepatology 48:978\u2013990","journal-title":"Hepatology"},{"key":"1_CR173_1","unstructured":"Zimmerman (1999a) Drug-induced liver disease. In: Schiff E, Sorrell M, Maddrey W (eds) Schiff's diseases of the liver. Lippincott-Raven, Philadelphia, pp 973\u20131064"},{"key":"1_CR174_1","unstructured":"Zimmerman HJ (1999b) Hepatotoxicity. The adverse effects of drugs and other chemicals on the liver, 2nd edn. Lippicott Williams & Wilkins, Philadelphia"},{"key":"1_CR175_1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/hep.1840040223","volume":"4","author":"HJ Zimmerman","year":"1984","unstructured":"Zimmerman HJ, Lewis JH, Ishak KG, Maddrey WC (1984) Ticrynafen-associated hepatic injury: analysis of 340 cases. Hepatology 4:315\u2013323","journal-title":"Hepatology"}],"container-title":["Handbook of Experimental Pharmacology","Adverse Drug Reactions"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-00663-0_1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T01:49:49Z","timestamp":1739411389000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-00663-0_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,21]]},"ISBN":["9783642006623","9783642006630"],"references-count":175,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-00663-0_1","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,21]]}}}